DE EN ABOUT US PRODUCTS DISCOUNT CONTRACTS PHARMACIES / WHOLESALE PRESS RELEASES CONTACT ABOUT US HEC Pharm GmbH is the German subsidiary of Sunshine Lake Pharma Co., LTD, China. Organizationally, both companies belong to the HEC Pharm Group, China. For HEC Pharm, research and development is the engine of the company. For this purpose, we have our own modern research center in China. More than 1500 scientists work here on the development of generics, new pharmaceutical products and biologicals. It is our principle to independently develop all generic products that we bring to the European market together with our team. The clinical studies required for product registration (bioequivalence studies) are carefully checked by our team in accordance with the GCP guidelines (Good Clinical Practice). Our pharmaceutical manufacturing facilities in China are of the highest quality standard. This high standard has been confirmed by inspections by the European and American (FDA) pharmaceutical authorities and the WHO. All products imported to Europe are checked again in Germany for their quality and approved for the European market in accordance with the German Medicines Act (AMG). © 2021 - HEC Pharm GmbH | Gabriele-Tergit-Promenade 17 | 10963 Berlin, Deutschland | info@hecpharm.de We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settings ACCEPT

DE EN ABOUT US PRODUCT INFORMATION DISCOUNT CONTRACTS PHARMACIES / WHOLESALE PRESS RELEASES CONTACT ABOUT US HEC Pharm GmbH is the German subsidiary of Sunshine Lake Pharma Co., LTD, China. Organizationally, both companies belong to the For HEC Pharm, research and development is the engine of the company. We have our own modern research center in China for this purpose. More than 1500 scientists work here on the development of generics, new pharmaceutical products and biologics. It is our principle to develop all generic products that we bring into the European market independently together with our team. The clinical studies (bioequivalence studies) required for product registration are carefully checked by our team in accordance with GCP guidelines (Good Clinical Practice). Our drug manufacturing facilities in China are of the highest quality standard. This high standard is proven by inspections by the European and American (FDA) drug authorities and the WHO. All products imported to Europe are checked for quality again in Germany and approved for the European market in accordance with the German Medicines Act (AMG). © 2021 - HEC Pharm GmbH | Gabriele Tergit Promenade 17 | 10963 Berlin, Germany | info@hecpharm.de We use cookies to continuously improve the information we offer and to show you content tailored to your interests. Please click on "Accept" to agree to the use of all cookies. Cookie settings ACCEPT